The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
NCT07285044 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2026-05-18
Summary
This phase II trial studies whether providing cancer treatment in the home is preferred over the traditional clinic setting and if it improves treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas. Typically, drug-related cancer care is provided at a medical center which causes patients to have to spend considerable time away from their family, friends, and familiar surroundings. This may add to the physical, emotional, social, and financial burden for patients and their families during this difficult time in their lives. The Cancer Connected Access and Remote Expertise (CARE) Beyond Walls (CCBW) program uses a specialized care team trained to provide cancer treatment in the patient's home setting. It is designed to support remote connection between the home health team and providers and Mayo clinic. This may be preferred over the traditional clinic setting which may improve treatment satisfaction in cancer patients living in the Florida Panhandle and surrounding areas.
Conditions
- Amyloidosis
- Basal Cell Carcinoma
- Biliary Tract Carcinoma
- Bladder Carcinoma
- Breast Carcinoma
- Cervical Carcinoma
- Colorectal Carcinoma
- Endometrial Carcinoma
- Fallopian Tube Carcinoma
- Gastroesophageal Junction Carcinoma
- Glioblastoma
- Head and Neck Carcinoma
- Hematopoietic and Lymphatic System Neoplasm
- Hepatocellular Carcinoma
- Hodgkin Lymphoma
- Lung Carcinoma
- Malignant Solid Neoplasm
- Mantle Cell Lymphoma
- Melanoma
- Merkel Cell Carcinoma
- Multiple Myeloma
- Myelodysplastic Syndrome
- Ovarian Carcinoma
- Pancreatic Carcinoma
- Primary Peritoneal Carcinoma
- Prostate Carcinoma
- Renal Cell Carcinoma
- Squamous Cell Carcinoma
- Urothelial Carcinoma
Interventions
- DRUG
-
Cancer Therapeutic Procedure
Receive in-home standard of care cancer-treatment
- DRUG
-
Cancer Therapeutic Procedure
Receive in-clinic standard of care cancer-treatment
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Roxana S. Dronca, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-18
- Primary Completion
- 2026-12-18
- Completion
- 2026-12-18
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
NCT00003284 ·Status: UNKNOWN ·Phase: PHASE2
-
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT00742924 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00014508 ·Status: COMPLETED ·Phase: PHASE2
-
Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
NCT05971056 ·Status: TERMINATED ·Phase: NA
-
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
NCT00006233 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma
NCT00645632 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
NCT00003852 ·Status: TERMINATED ·Phase: PHASE2
-
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002552 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004903 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
NCT00002931 ·Status: COMPLETED ·Phase: PHASE2
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
NCT06860880 ·Status: RECRUITING ·Phase: NA
-
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00003402 ·Status: COMPLETED ·Phase: PHASE2
-
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
NCT01946854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission
NCT02128230 ·Status: TERMINATED ·Phase: PHASE2
-
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
NCT02421354 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
NCT00005958 ·Status: UNKNOWN ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
NCT00003401 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
NCT00005941 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
NCT00002854 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
NCT05033288 ·Status: RECRUITING
-
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NCT00027820 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma
NCT00002524 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
NCT00002592 ·Status: COMPLETED ·Phase: PHASE2
-
Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant
NCT00238368 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
NCT00019864 ·Status: TERMINATED ·Phase: PHASE2